Holdings
21
Concentrated
Top 10 weight
76%
Concentration
Active share
-
Style
Equity
-
Asset allocation
Portfolio
3Sectors
17High-conviction bets
79%Top sector wt.
-Cash
Market-cap allocation
Large cap61%
Mid cap37%
Small cap2%
Asset allocation
Asset mix not available.
Top holdings
18.4%
8.2%
8.1%
7.7%
Cipla LimitedEQUITY
7.6%6.9%
Lupin LimitedEQUITY
5.3%Laurus Labs LimitedEQUITY
5.1%4.7%
4.5%
Aurobindo Pharma LimitedEQUITY
3.8%3.3%
3.1%
Biocon LimitedEQUITY
3.0%2.6%
Mankind Pharma LimitedEQUITY
2.6%2.0%
Abbott India LimitedEQUITY
1.4%Piramal Pharma LimitedEQUITY
1.0%0.8%
Net Receivables / (Payables)CASH_EQUIVALENT
0.0%Clearing Corporation of India LtdCASH_EQUIVALENT
0.0%AI Smart summary
Pros
- Large-cap tilt (61%) - relatively stable.
Cons
- Compact 21-stock portfolio - higher single-stock impact.
- High top-10 concentration (76%).
- Concentrated in Pharmaceuticals & Biotechnology - watch sector risk.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
79.5%
20.5%